Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients

BACKGROUND: Dosing in obese critically ill patients is challenging due to pathophysiological changes derived from obesity and/or critical illness, and it remains fully unexplored. This study estimated the micafungin probability of reaching adequate 24-h area under the curve (AUC(0–24h))/minimum inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Maseda, Emilio, Grau, Santiago, Luque, Sonia, Castillo-Mafla, Maria-Pilar, Suárez-de-la-Rica, Alejandro, Montero-Feijoo, Ana, Salgado, Patricia, Gimenez, Maria-Jose, García-Bernedo, Carlos A., Gilsanz, Fernando, Roberts, Jason A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899833/
https://www.ncbi.nlm.nih.gov/pubmed/29655372
http://dx.doi.org/10.1186/s13054-018-2019-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899833/
https://www.ncbi.nlm.nih.gov/pubmed/29655372
http://dx.doi.org/10.1186/s13054-018-2019-8

Ejemplares similares